After Mohs: The Operation That Removes the Cancer Is Not the One That Decides How Your Face Looks

A patient notices a pearly bump on the side of the nose that bleeds when she washes her face. A biopsy comes back basal cell carcinoma. She is referred for Mohs surgery, told the cure rate is around ninety nine percent, and given a date. Every part of that conversation is accurate and reassuring, and none of it addresses Mohs reconstruction, which is the part of the day that will determine what her face looks like for the rest of her life.

She arrives at seven in the morning. The tumor is removed in two stages over four hours. Somewhere around noon she is handed a mirror and shown a circular defect on the side of her nose roughly the size of a dime, and a decision about how to close it is made in the next ten minutes, in a chair, under local anesthetic, by whoever is standing there.

That sequence is standard. It is also the point at which the most consequential surgical judgment of the entire episode gets compressed into the smallest amount of consultation time.

Mohs is a margin technique, and it says nothing about closure

The short answer: Mohs micrographic surgery removes skin cancer in stages while the entire surgical margin is examined under a microscope during the appointment, which produces the highest cure rates and the smallest defects. It is an oncologic technique. It contains no instructions about what happens to the wound.

Frederic Mohs developed the method at the University of Wisconsin in the 1930s, and the modern fresh tissue version has been the standard of care for facial skin cancer for decades. The mechanical difference from a standard excision is worth understanding because it explains both the cure rate and the shape of the wound. In a conventional excision, the specimen is sectioned vertically like a loaf of bread and the pathologist reads slices. The proportion of the true margin actually visualized by that method is commonly estimated at under two percent. In Mohs, the tissue is oriented, mapped, and sectioned horizontally so that essentially the complete peripheral and deep margin is examined, and any residual tumor is traced back to its exact location on the map before another layer is taken.

The result is a technique with cure rates the rest of oncologic surgery envies. The American College of Mohs Surgery and the published literature put five year cure near ninety nine percent for previously untreated basal cell carcinoma and around ninety four percent for recurrent tumors, with squamous cell carcinoma close behind. Because tumor is traced rather than guessed at, the surgeon takes less normal tissue than a wide excision would require, which is precisely why it is used on faces.

Volume is the other reason this matters to more people than expect it to. A widely cited analysis in JAMA Dermatology estimated more than five million keratinocyte carcinomas treated in the United States in a single year, in roughly three million people. The American Academy of Dermatology puts lifetime skin cancer risk at about one in five Americans. This is not a rare event that happens to other people. In sun exposed populations it is closer to a routine feature of middle age.

The 2012 Appropriate Use Criteria published jointly by the dermatology and Mohs surgery societies sorted hundreds of clinical scenarios into appropriate and inappropriate, and the anatomic zone where Mohs is most consistently indicated is the central face: nose, eyelids, lips, ears, temples, and the periorbital region. That is not a coincidence. Those are the areas where taking an extra five millimeters of normal tissue has visible consequences, and they are also the areas where reconstruction is hardest.

"

The cure rate is the number everyone quotes and the reconstruction is the thing everyone sees. Patients are counseled extensively about the first and handed the second in a mirror.

"

The repair may be a second operation, and sometimes a second surgeon

The short answer: Mohs surgeons are dermatologists with subspecialty fellowship training, and many perform their own repairs to a very high standard. Others refer complex defects to facial plastic, oculoplastic, or plastic surgery, and which of those two paths applies to you is rarely discussed before the day of the excision.

Micrographic surgery and dermatologic oncology is now a formally recognized subspecialty with accredited fellowship training, and that training includes reconstruction. A fellowship trained Mohs surgeon who repairs several hundred facial defects a year is, on that specific task, one of the most experienced operators a patient could find. The difficulty is not that dermatologic surgeons close wounds. It is that the referral pattern is invisible to the patient in advance.

Some practices repair essentially everything they excise. Some repair straightforward defects and refer nasal, eyelid, and lip reconstruction out. Some send the patient across town the same afternoon, and some schedule the repair for the following morning with the wound dressed overnight, which is an entirely acceptable practice that patients nonetheless find alarming when nobody mentioned it as a possibility. A patient who assumed one appointment and one surgeon can find themselves meeting the person who will actually reconstruct their nose for the first time while the defect is already open. The general problem of not knowing who is holding the instruments is examined in the question of who is actually operating on you, and it applies here in a form that is usually accidental rather than concealed.

The fix is a single question asked at the consultation weeks earlier, and the answer costs nothing to give.

The reconstructive ladder, and the borders that punish shortcuts

The short answer: the options run from letting the wound heal open, through grafts, to local flaps, and the choice is governed less by the size of the defect than by how close it sits to the eyelid margin, the nostril rim, and the lip.

Leaving a wound to heal by secondary intention is a legitimate reconstruction, not a failure to reconstruct. Work associated with John Zitelli established that concave surfaces of the nose, eye region, ear, and temple frequently heal open with cosmetic results that match or beat a graft. On convex surfaces, the same approach tends to produce a depressed, pale, tethered scar.

Skin grafts import tissue from elsewhere. A full thickness graft from preauricular or supraclavicular skin carries better color and texture than a split thickness graft, but any graft is borrowed skin dropped into a new neighborhood, and the mismatch in color, thickness, and sebaceous quality is what produces the patch appearance patients recognize immediately in photographs.

Local flaps recruit adjacent skin that already matches in color, texture, and thickness, and move it on its own blood supply. Advancement, rotation, transposition, bilobed, and rhombic designs all exist because different defects want tension pulled in different directions. The design question is almost never how to close the hole. Any competent surgeon can close a hole. The question is where the tension vector points, because the mobile borders of the face have no bone behind them and will move if pulled.

That is the entire reason facial reconstruction is difficult. A closure under tension below the eye rotates the lower lid outward, producing ectropion, a lid that no longer touches the globe, and a patient with a chronically watering, irritated eye. The lower lid is a structure that misbehaves under tension in cosmetic surgery too, a pattern set out in what blepharoplasty can and cannot fix. Pull on the nostril rim and the ala retracts, so one nostril sits higher than the other and the nose reads as asymmetric in every photograph. Pull across the vermilion border and the lip notches. These are not rare complications. They are the predictable consequence of treating a facial defect as a geometry problem.

The subunit principle and the flap that stays attached for three weeks

The short answer: nasal reconstruction follows a rule that surprises patients, which is that surgeons sometimes remove additional healthy skin on purpose, and the best repairs for large nasal defects keep the flap attached to its original blood supply for about three weeks before it is divided.

In 1985, Gary Burget and Frederick Menick published the subunit principle in Plastic and Reconstructive Surgery, and it reorganized how the nose is repaired. The nose is treated as a set of aesthetic subunits: dorsum, sidewalls, tip, alae, and soft triangles. Scars placed at the borders between subunits hide in shadow lines and read as normal anatomy. Scars placed across the middle of a subunit sit in a flat expanse of skin and announce themselves. When more than roughly half a subunit is missing, the recommendation is to remove the remainder and resurface the whole unit, because a slightly larger wound closed along anatomic borders looks better than a smaller one closed through the middle of the tip.

The other principle is that the nose has three layers, and a full thickness defect needs all three rebuilt: lining on the inside, a cartilage framework in the middle, and skin on the outside. Skip the cartilage and the reconstruction looks acceptable for a few months and then collapses inward as it contracts, narrowing the airway. A nose that looks reasonable but does not move air is a failed reconstruction, a point that connects to the broader argument in functional rhinoplasty and the relationship between breathing and appearance.

That is where the staged flaps come in. The paramedian forehead flap takes skin from the central forehead on a narrow pedicle based on the supratrochlear vessels, rotates it down to the nose, and leaves the pedicle bridging across the space between the eyebrows for roughly three weeks while the transferred tissue establishes its own blood supply. Then the pedicle is divided and inset in a second operation, often with a third refinement stage. The melolabial interpolated flap does something similar for the ala from the cheek. These are among the most reliable and best looking reconstructions in all of facial surgery, and they require a patient to spend three weeks in public with a strip of forehead skin crossing their face.

Patients who are told this in advance manage it. Patients told on the morning of surgery experience it as a catastrophe. The technical result is identical. The difference is entirely in the counseling, which is a recurring theme in how aesthetic outcomes are judged and one reason reading a before and after gallery carefully matters here as much as in elective work.

Timing, scars, and the revision nobody schedules

The short answer: a facial reconstruction looks its worst somewhere between four and eight weeks, improves for a year, and frequently includes a planned refinement stage that patients mistake for a complication.

Flaps are thicker than the skin around them and pass through a phase of firmness, pinkness, and a pincushioned contour as they contract and remodel. That phase peaks in the second month and resolves slowly. The single most common error patients make is judging the result during the worst window and concluding it failed. What actually helps during that period is unglamorous and well documented: sun protection, tension control, silicone, and time, the evidence for which is laid out in what scar care after surgery actually supports.

Refinement is often planned from the start. Dermabrasion of a forehead flap at around six to eight weeks is a recognized step in the sequence, not a rescue. Thinning, contour adjustment, and scar revision at six months to a year are ordinary. A surgeon who tells you at the outset that the reconstruction is a two or three step process is describing the standard of care, and one who promises a single perfect operation on a full thickness nasal defect is describing something else.

Two other things belong in the conversation. Melanoma and melanoma in situ are sometimes handled with delayed reconstruction, the wound dressed while permanent sections and immunostains are read over a day or more, because the margin question is harder than it is with basal cell carcinoma. And skin cancer in patients with deeper skin tones is less common but diagnosed later and at a more advanced stage, with worse survival in melanoma, a disparity the American Academy of Dermatology attributes substantially to delayed detection. Reconstruction on darker skin also carries a higher risk of hyperpigmented and hypertrophic scarring, which changes both technique and aftercare, an issue that runs through where the real risk sits in cosmetic procedures on deeper skin tones.

The honest summary

Mohs surgery is one of the genuine successes of modern oncologic technique. The cure rates are real, the tissue sparing is real, and a patient who has been told to have Mohs on a facial skin cancer is being given the right advice. None of that is in question.

What is in question is the half of the day nobody prepares patients for. The excision and the reconstruction are separate operations governed by separate skills, and the second one is what people see in the mirror for the next thirty years. The decisions that determine the result are made quickly, on the day, in a chair, under time pressure, and they are made far better when the patient already knows who is repairing the wound, what the plausible repairs are, whether a staged flap is possible, and what the borders near the defect will do if pulled.

Three things are worth carrying into the referral appointment. Ask who performs the reconstruction and meet them in advance if it is not the same person. Ask which repairs are plausible for your location and whether any of them take more than one stage, because a three week forehead flap explained in advance is a plan and the same flap explained on the day is a shock. And ask how many facial reconstructions in your specific location the operating surgeon does in a year, using the framing in how many have you done, because the nose, the eyelid, and the lip are not interchangeable and volume in one does not transfer to the others.

The patients who come out of this well are not the ones who found a better cure rate. Cure rates are already excellent almost everywhere the operation is performed properly. They are the ones who understood, before the tumor came out, that a second operation was coming, and treated the choice of who performed it with the same seriousness they would have given an elective procedure they were paying for themselves.